Doug C. Biehn

Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.

Inoveon Corp. provides medical services. It delivers solutions to detect, stage and monitor diseases affecting the eye diabetic retinopathy, macular degeneration, and glaucoma. The firm helps patients and their providers improve diabetic retinopathy care through Inoveon diagnostic service centers. The company was founded by Stephen R. Fransen, G. Carl Gibson and P. Lloyd Hildebrand in 1999 and is headquartered in Oklahoma City, OK.

Nexidia, Inc. provides interaction analytics solutions. The firm's services include consulting, managed analytic, training, customer advocacy, hosting, and deployment and support. The company was founded by Peter S. Cardillo, Kenneth K. Griggs, and Mark A. Clements in 2000 and is headquartered in Atlanta, GA.

Xoft, Inc. develops Electronic Brachytherapy systems for radiation therapy applications. Its products include the Axxent Controller, which utilizes a miniaturized high dose rate (HDR) X-ray source to apply radiation directly to the cancerous tumor bed; Axxent HDR X-ray Source, a low energy radiation treatment without the use of radioactive isotopes; Axxent Applicators, which provides a channel for the Axxent X-ray Source to deliver high dose rate, low energy radiation directly to the targeted area; and Axxent Accessories, an accessory product line designed to support and aid a physician during a procedure or treatment of cancer radiation. The company was founded by Michael Forman in 1998 and is headquartered in San Jose, CA.

Crescendo Bioscience, Inc. develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases. It develops quantitative, objective, reproducible blood tests to provide rheumatologists with deeper clinical insight to help enable more effective management of patients with autoimmune and inflammatory diseases. The company was founded by Mike B. Centola and Christopher L. Sutton in July 2002 and is headquartered in South San Francisco, CA.

Medtronic Monitoring, Inc. treats cardiac arrhythmias. The company was founded in 2005 and is headquartered in San Jose, CA.

HeartFlow, Inc. operates as a cardiovascular company which engages in diagnosing coronary artery diseases. The firm provides a patient-specific analysis of coronary blood flow utilizing coronary CT scans and proprietary computer algorithms based on computational fluid dynamics. The company was founded by Charles A. Taylor, Nathan M. Wilson, and Christopher K. Zarins in 2007 and is headquartered in Redwood City, CA.

AbleTo, Inc. engages in the provision of technology-enabled virtual behavioral health care. It offers a structured medical program which involves private one-on-one with a professional therapist or coach via phone or video chat. The company was founded by Michael B. Laskoff and Peter Pramataris in 2008 and is headquartered in New York, NY.

Patientco Holdings, Inc. provides cloud-based payment technology. It offers a platform designed to help patients understand and pay their healthcare bills, and help providers improve their revenue cycle. The company was founded by Bird D. Blitch and Joshua Silver in 2008 and is headquartered in Atlanta, GA.

The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA.

Sanford C. Bernstein & Co. LLC is a registered broker-dealer headquartered in New York City. The firm was founded in 1967 and is a subsidiary of Alliance Capital Management LLC, ultimately held by Equitable Holdings, Inc. (NYSE: EQH). Sanford C. Bernstein & Co. provides trading and executions services to their clients.

American Cancer Society, Inc. provides information on cancer occurrence, survival, prevention, early detection, and treatment. The non-profit company is based in Kennesaw, GA and has subsidiaries in the United States. The company's SHES department is an intramural research program with world-renowned epidemiologists and health scientists. The company was founded in 1913 by Candy Arrington. Karen E. Knudsen has been the CEO of the company since 2021.

Life Technologies Clinical Services Lab, Inc. offers clinically guided personal genetic testing services for customers. The firm develops and commercializes genetics-based products and services to enhance individual health and wellness; and educates and empowers individuals and their physicians by providing personalized genetic insights about disease risk and medication response to catalyze behavior change and inform clinical decision-making. The company was founded by David B. Agus and Dietrich A. Stephan in 2006 and is headquartered in Foster City, CA.

Oncology Analytics, Inc. provides oncology benefits management solutions. Its services include rapid, easy-to-use prior authorization services with proven ROI, clinical decision support, physician education and expert peer review, oncology network evaluation and optimization consulting services, patented, value-based reimbursement methods and tools and comprehensive performance reporting and analytics. The company was founded by Marc Fishman, Ann Huntress Lamont and Danielle Fishman in 2009 and is headquartered in Plantation, FL.

Twinstrand Biosciences, Inc. develops technologies to detect ultra-rare variants. It uses technology for new generation of clinical diagnostics and tools for scientific discovery. The company was founded by Jesse Salk and Michael Schmitt in 2015 and is headquartered in Seattle, WA.

Upward Health Solutions Rhode Island Administration LLC operates as a specialty care coordination organization that partners with health plans and providers to help patients with severe mental illness or substance abuse disorder improve their health and functioning through intensive condition management and promoting access to effective therapy. The company was founded by Bradley Bennett, Eric Heil, and Thomas Hawes and is headquartered in Providence, RI.

Cradle Genomics, Inc. engages in researching and developing life sciences. The company was founded by Randy Armant, Richard Shippy and Sascha Drewlo and is headquartered in San Diego, CA.

Octave Health Group, Inc. provides therapy services. It offers coaching and classes and group sessions related to anxiety, depression, chronic insomnia, bipolar disorder, trauma, chronic pain, personality perfectionism, anger management, relationships, intimacy, work stress, parenthood, and related general issues. The company was founded by Kristen Scarlett, Sarah Gundle, and Sandeep Acharya and is headquartered in New York, NY.

Perspectum Group Plc engages in the sale of diagnostic products via a software-as-a-medical device platform. Its products combine expertise in image formation, magnetic resonance image analysis and artificial intelligence to support healthcare provider diagnosis, treatment decision-making, and monitoring of the progression of chronic metabolic diseases, multi-organ pathologies and cancer, and determine whether the patient is responding to therapy. Its products include Liver MultiScan, MRCP+, Hepatica, and CoverScan MD. The company was founded by Matthew Robson on June 10, 2021 and is headquartered in Oxford, the United Kingdom.

Exai Bio, Inc. is an American next-generation liquid biopsy company founded by Hani Goodarzi, Babak Alipanahi, and Patrick Arensdorf. The company's mission is to enable early detection, accurate diagnosis, personalized and targeted treatment, and ultimately cure of cancer. Exai Bio's proprietary RNA- and AI-based liquid biopsy technology delivers clinical insights into cancer biology to enable the earliest and most accurate diagnosis of cancer. Patrick Arensdorf has been the CEO since incorporation.